Position in CELU
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$99,955
-$154,175 QoQ
Shares Held
167,150
-12.5% QoQ
Ownership
0.577%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 39 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CELU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. CELU ranks #441 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CELU
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $99,955 | 167,150 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $254,130 | 191,076 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $177,810 | 160,190 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $288,379 | 139,314 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $264,256 | 134,825 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $235,350 | 136,041 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $273,540 | 131,510 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $408,296 | 137,474 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $443,066 | 141,555 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $704,182 | 134,643 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $241,592 | 978,106 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $217,139 | 978,106 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $467,511 | 877,133 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $718,661 | 1,159,132 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,486,657 | 1,152,448 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,635,850 | 1,141,061 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $645,265 | 189,784 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $614,150 | 70,511 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $361,016 | 70,511 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $471,202 | 66,554 | Shares | Defined | 2021-11-12 | |
| 2020-09-30 GXGX | — | 10,000 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||